Sanofi to restructure Newton diabetes startup Onduo, saying it 'over-invested'

By | Published Wednesday, December 11, 2019

[unable to retrieve full-text content]Sales of Sanofi's diabetes and cardiovascular products have been on the decline, dropping 14 percent to $4.1 billion between the fourth quarter of 2018 and third quarter of 2019. Meanwhile, Hudson ...

Bookmark the permalink. RSS feed for this post.

Leave a Reply

Powered by Blogger.

Search

Swedish Greys - a WordPress theme from Nordic Themepark. Converted by LiteThemes.com.